McGuire Investment Group LLC Lowers Position in SPDR S&P Biotech ETF $XBI

McGuire Investment Group LLC cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 93.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,306 shares of the exchange traded fund’s stock after selling 110,614 shares during the quarter. McGuire Investment Group LLC’s holdings in SPDR S&P Biotech ETF were worth $689,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently modified their holdings of the company. Provident Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 3,000.0% during the first quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock valued at $25,000 after acquiring an additional 300 shares during the last quarter. Garrison Bradford & Associates Inc. purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter valued at approximately $39,000. Compass Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 46.0% during the first quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock valued at $51,000 after acquiring an additional 200 shares during the last quarter. Golden State Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock valued at $52,000 after acquiring an additional 319 shares during the last quarter. Finally, Avalon Trust Co purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter valued at approximately $57,000.

SPDR S&P Biotech ETF Trading Up 1.2%

Shares of XBI opened at $101.39 on Thursday. The company has a market capitalization of $5.52 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. The stock has a 50 day moving average of $91.48 and a 200 day moving average of $84.95. SPDR S&P Biotech ETF has a 12 month low of $66.66 and a 12 month high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.